The biochemical features of two patients with phaeochromocytomas illustrate the inadvisability of depending on a single group of analytes for the diagnosis. The first case presented as a surgical emergency with retroperitoneal haemorrhage. Biochemical diagnosis was difficult since total 24 hour urinary free catecholamine excretion was within normal limits in two out of three samples, and only marginally raised in the third with an atypical preponderance of adrenaline. Plasma catecholamine concentrations were also normal. But urinary excretion of the catecholamine metabolites, metadrenaline and 4-hydroxy-3-methoxy mandelic acid (HMMA), was consistently raised. In contrast, the second patient presenting with headache and labile hypertension showed normal metabolite excretion in the face of grossly increased free noradrenaline excretion and raised plasma noradrenaline concentrations.
Phaeochromocytoma is an important diagnosis to make, because it is due to a benign, curable tumour in 90% of cases.' Although rare in the general population, the incidence in hypertensive patients has been estimated to be between 1 in 1000 and 1 in 2500.2 3 Diagnosis is difficult and major reliance is placed on biochemical investigation for confirmation and on expensive imaging techniques for localisation of the tumour. There is as yet no consensus on the best single biochemical test, but measurement of 24 hour urinary free (unconjugated) catecholamines (noradrenaline, adrenaline, and dopamine), using high performance liquid chromatography (HPLC) with electrochemical detection, has been recommended as a suitable first line investigation.4 This is mainly because it overcomes the problems of drug and dietary interference encountered with earlier assays of either 4-hydroxy-3-methoxy mandelic acid (HMMNA, formerly known as vanillyl mandelic acid or VMA) and the 3-methoxy amine metabolites, normetadrenaline and metadrenaline.
We report two cases of phaeochromocytoma in which biochemical tests were falsely negative, forcing us to alter our investigative protocol. Both urine specimens from case 2 were collected before removal of the phaeochromocytoma. Urinary free dopamine excretion, not reported, was measured in all specimens and was within normal limits (<3.0,umol/24 h). Note that the upper limit of the reference ranges were derived from a hypertensive population without phaeochromomytoma, with abnormal results indicated by an asterisk. HMMA = 4-hydroxy-3-methoxy mandelic acid; HVA = homovanillic acid.
A 5 x 4 cm phaeochromocytoma was subsequently removed from the lower end of the para-aortic sympathetic chain, effectively curing the patient's hypertension and headaches.
Discussion
The first patient with a phaeochromocytoma presented with retroperitoneal haemorrhage, which is unusual but well documented.' The correct diagnosis was not suspected until the patient had undergone emergency laparotomy, which could have been fatal in a patient with a catecholamine producing tumour. 3 In retrospect the four year history of episodic palpitations and breathlessness were probably manifestations of the underlying condition, because these symptoms have not recurred since removal of the tumour. This case illustrates the "diagnosis gap" which can occur between the onset of symptoms and confirmation of phaeochromocytoma. 6 It was disappointing, but not surprising in the light of our past experience,5 to find normal plasma catecholamine concentrations in the preoperative blood of this patient. However, it was a matter of great concern to find that measurement of urinary free catecholamines failed to detect any abnormality in two of three urine collections from this patient, while the urinary excretion of the was reported that increased excretion of either adrenaline or noradrenaline gave 100% diagnostic sensitivity.9 Equal sensitivity was attained by the excretion of either metadrenaline or normetadrenaline, at the cost of reduced specificity. Measurement of total catecholamines (the sum of noradrenaline and adrenaline) and total metadrenalines (the sum of normetadrenaline and metadrenaline) was less sensitive than the constituents taken separately. HMMA had the lowest sensitivity (7 1 %).
Experience from the first case and the reports cited above would lead us to conclude that the urinary excretion of catecholamine metabolites should replace the measurement of the free catecholamine excretion in the diagnosis of phaeochromocytoma. However, complete reliance on urinary total metadrenaline excretion would have caused us to miss the phaeochromocytoma in the second patient, who presented with the more classic features of phaeochromocytoma-headaches, anxiety attacks, and labile hypertension. 4 Clinicians should be encouraged to consider the diagnosis of phaeochromocytoma more frequently.
